» Articles » PMID: 37081739

Standardization of Organoid Culture in Cancer Research

Overview
Journal Cancer Med
Specialty Oncology
Date 2023 Apr 21
PMID 37081739
Authors
Affiliations
Soon will be listed here.
Abstract

Establishing a valid in vitro model to represent tumor heterogeneity and biology is critical but challenging. Tumor organoids are self-assembled three-dimensional cell clusters which are of great significance for recapitulating the histopathological, genetic, and phenotypic characteristics of primary tissues. The organoid has emerged as an attractive in vitro platform for tumor biology research and high-throughput drug screening in cancer medicine. Organoids offer unique advantages over cell lines and patient-derived xenograft models, but there are no standardized methods to guide the culture of organoids, leading to confusion in organoid studies that may affect accurate judgments of tumor biology. This review summarizes the shortcomings of current organoid culture methods, presents the latest research findings on organoid standardization, and proposes an outlook for organoid modeling.

Citing Articles

From morphology to single-cell molecules: high-resolution 3D histology in biomedicine.

Xu X, Su J, Zhu R, Li K, Zhao X, Fan J Mol Cancer. 2025; 24(1):63.

PMID: 40033282 PMC: 11874780. DOI: 10.1186/s12943-025-02240-x.


Effects of hydrogel stiffness and viscoelasticity on organoid culture: a comprehensive review.

Lai W, Geliang H, Bin X, Wang W Mol Med. 2025; 31(1):83.

PMID: 40033190 PMC: 11877758. DOI: 10.1186/s10020-025-01131-7.


Tumor organoids in cancer medicine: from model systems to natural compound screening.

Cong R, Lu C, Li X, Xu Z, Wang Y, Sun S Pharm Biol. 2025; 63(1):89-109.

PMID: 39893515 PMC: 11789228. DOI: 10.1080/13880209.2025.2458149.


Progress in spinal cord organoid research: advancing understanding of neural development, disease modelling, and regenerative medicine.

Huang R, Zhu Y, Chen H, Yu L, Liu Z, Liu Y Biomater Transl. 2025; 5(4):355-371.

PMID: 39872925 PMC: 11764192. DOI: 10.12336/biomatertransl.2024.04.003.


Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method.

Feng Q, Shan X, Yau V, Cai Z, Xie S Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861125 PMC: 11769033. DOI: 10.3390/ph18010062.


References
1.
van de Wetering M, Francies H, Francis J, Bounova G, Iorio F, Pronk A . Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015; 161(4):933-45. PMC: 6428276. DOI: 10.1016/j.cell.2015.03.053. View

2.
Cruz-Acuna R, Quiros M, Farkas A, Dedhia P, Huang S, Siuda D . Synthetic hydrogels for human intestinal organoid generation and colonic wound repair. Nat Cell Biol. 2017; 19(11):1326-1335. PMC: 5664213. DOI: 10.1038/ncb3632. View

3.
Kenny P, Lee G, Myers C, Neve R, Semeiks J, Spellman P . The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2008; 1(1):84-96. PMC: 2391005. DOI: 10.1016/j.molonc.2007.02.004. View

4.
Hu L, Yang X, Lan H, Fang X, Chen X, Jin K . Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold. Exp Cell Res. 2021; 408(2):112858. DOI: 10.1016/j.yexcr.2021.112858. View

5.
Baker L, Tiriac H, Clevers H, Tuveson D . Modeling pancreatic cancer with organoids. Trends Cancer. 2016; 2(4):176-190. PMC: 4847151. DOI: 10.1016/j.trecan.2016.03.004. View